Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy St J Thomas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|May 16, 2009
Quality assurance in Her-2 testing--redefining the gold standardJeremy St J Thomas
BMJ (Clinical Research Ed.)|August 13, 2009
Breast screening overdiagnosis. Protocols are evidence basedHilary M Dobson, Jeremy St J Thomas
Histopathology|September 13, 2011
Constructing tissue microarrays from core needle biopsies of breast cancersRia Kishen, John M S Bartlett, J Michael J Dixon, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|July 28, 2010
Changes in chromatin structure during processing of wax-embedded tissue sectionsElizabeth Kerr, Tomoharu Kiyuna, Shelagh Boyle, et al.
Histopathology|October 23, 2009
Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-upJeremy St J Thomas, Gillian R Kerr, Wilma J L Jack, et al.
The Journal of Pathology|March 21, 2012
Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progressionMelanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
The Journal of Pathology|November 16, 2012
Authors' replyMelanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane ProjectAlastair M Thompson, Karen Clements, Shan Cheung, et al.
Breast Cancer Research and Treatment|May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancerMelanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Breast Cancer Research and Treatment|March 11, 2011
The p160 ER co-regulators predict outcome in ER negative breast cancerMelanie Spears, Steffi Oesterreich, Ilenia Migliaccio, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|May 16, 2009
Quality assurance in Her-2 testing--redefining the gold standardJeremy St J Thomas
BMJ (Clinical Research Ed.)|August 13, 2009
Breast screening overdiagnosis. Protocols are evidence basedHilary M Dobson, Jeremy St J Thomas
Histopathology|September 13, 2011
Constructing tissue microarrays from core needle biopsies of breast cancersRia Kishen, John M S Bartlett, J Michael J Dixon, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|July 28, 2010
Changes in chromatin structure during processing of wax-embedded tissue sectionsElizabeth Kerr, Tomoharu Kiyuna, Shelagh Boyle, et al.
Histopathology|October 23, 2009
Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-upJeremy St J Thomas, Gillian R Kerr, Wilma J L Jack, et al.
The Journal of Pathology|March 21, 2012
Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progressionMelanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
The Journal of Pathology|November 16, 2012
Authors' replyMelanie Spears, Carrie A Cunningham, Karen J Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane ProjectAlastair M Thompson, Karen Clements, Shan Cheung, et al.
Breast Cancer Research and Treatment|May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancerMelanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Breast Cancer Research and Treatment|March 11, 2011
The p160 ER co-regulators predict outcome in ER negative breast cancerMelanie Spears, Steffi Oesterreich, Ilenia Migliaccio, et al.
Pageof 1